Literature DB >> 22454190

Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth.

Stephanie Ghislin1, Frederique Deshayes, Jessica Lauriol, Sandrine Middendorp, Isabelle Martins, Reem Al-Daccak, Catherine Alcaide-Loridan.   

Abstract

Melanoma tumors have been shown to comprise both invasive and proliferative cell subpopulations. These populations are highly plastic, thus hampering full characterization and therapeutic targeting of dormant and partially dedifferentiated invasive cells. We have reported, previously, that melanoma cells grown in a serum-free neural crest medium, in which they propagate as spheroids, show higher invasiveness and increased immune escape. In addition, in spheroids, we showed the increased expression of several genes which are involved in pluripotency, differentiation, and invasion. We therefore proposed that these culture conditions favor the polarization of proliferative melanoma cells toward an invasive state. As plasticity may suggest a reversible polarization, the aim of this report is to assess the transient phenotype of invasive cells generated through this procedure. We provide evidence that spheroid cells mimic dormant populations, and that this phenotype is fully reversible when cells are reintroduced into culture media that contain serum in which they grow as a monolayer. We also show that most transcriptional deregulations can be reversed. To further explain this plasticity in melanoma cells, we explored the epigenetic status of four gene promoters, assuming changes in acetylation or dimethylation on histone 3. We show reversible modifications on lysine 9 and lysine 4. We propose that spheroids allow the transient polarization of melanoma cells toward enhanced dormancy, loss of differentiation, and invasiveness, thereby reproducing the properties and plasticity of invasive subpopulations in melanoma tumors. This in-vitro model will allow further characterization and targeting of melanoma invasive cell populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454190     DOI: 10.1097/CMR.0b013e328351e7c4

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  11 in total

1.  Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.

Authors:  Aurelie Borrull; Stephanie Ghislin; Frederique Deshayes; Jessica Lauriol; Catherine Alcaide-Loridan; Sandrine Middendorp
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-11       Impact factor: 4.553

2.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

3.  Phenotypic diversity of patient-derived melanoma populations in stem cell medium.

Authors:  Malgorzata Sztiller-Sikorska; Mariusz L Hartman; Beata Talar; Justyna Jakubowska; Izabela Zalesna; Malgorzata Czyz
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

4.  A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations.

Authors:  Maria Angeles Bonmati-Carrion; Nuria Alvarez-Sánchez; Rüdiger Hardeland; Juan Antonio Madrid; Maria Angeles Rol
Journal:  Int J Mol Sci       Date:  2013-02-14       Impact factor: 5.923

5.  MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.

Authors:  Mariusz L Hartman; Beata Talar; Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

6.  Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.

Authors:  Yuval Peretz; Hong Wu; Shayan Patel; Alfonso Bellacosa; Richard A Katz
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

Review 7.  MITF in melanoma: mechanisms behind its expression and activity.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  Cell Mol Life Sci       Date:  2014-11-30       Impact factor: 9.261

8.  Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation.

Authors:  Lucia Kucerova; Lucia Demkova; Svetlana Skolekova; Roman Bohovic; Miroslava Matuskova
Journal:  BMC Cancer       Date:  2016-05-12       Impact factor: 4.430

9.  Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.

Authors:  Malgorzata Czyz; Kamila Koprowska; Malgorzata Sztiller-Sikorska
Journal:  Cancer Biol Ther       Date:  2012-11-28       Impact factor: 4.742

10.  Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.

Authors:  Mariusz L Hartman; Beata Talar; Muhammad Zaeem Noman; Anna Gajos-Michniewicz; Salem Chouaib; Malgorzata Czyz
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.